Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01979445 · ClinicalTrials.gov registry record · Phase 2
Cangrelor to Clopidogrel or Prasugrel Transition Study
A Phase 2 study, sponsored by The Medicines Company.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
NCT01979445 is a Phase 2 study that has completed, run by The Medicines Company. The registered enrollment target is 15 participants.
The verdict
NCT01979445, a Phase 2 study, has completed, sponsored by The Medicines Company.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
Study Summary
There are two separate objectives in this study: 1. To demonstrate the pharmacodynamic (PD) profile when participants treated with cangrelor are switched to oral prasugrel 60 mg administered 30 minutes (min) after cangrelor infusion is discontinued 2. To demonstrate the PD profile when participants treated with cangrelor are switched to oral clopidogrel 600 mg administered during or immediately after cangrelor infusion.
Interventions
- DRUG Clopidogrel
- DRUG Prasugrel
- DRUG Cangrelor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2013-12-02 |
| Est. Completion | 2014-01-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01979445
The ClinicalTrials.gov registry entry for NCT01979445 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Medicines Company, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Clopidogrel is the first listed.
NCT01979445 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01979445 about?
NCT01979445 is a clinical study titled "Cangrelor to Clopidogrel or Prasugrel Transition Study". There are two separate objectives in this study: 1. To demonstrate the pharmacodynamic (PD) profile when participants treated with cangrelor are switched to oral prasugrel 60 mg administered 30 minutes (min) after cangrelor infusion is discontinued 2. To demonstrate the PD profile when participants...
What is the current status of trial NCT01979445?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2013-12-02. Estimated completion is 2014-01-20.
What interventions are being tested in trial NCT01979445?
The interventions under investigation include: Clopidogrel (DRUG), Prasugrel (DRUG), Cangrelor (DRUG).
Who is sponsoring clinical trial NCT01979445?
This trial is sponsored by The Medicines Company, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.